Ankie M Harmsze

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Interstitial Lung Disease

Top Venues

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Marjolein Drent, Petal A Wijnen, Naomi T Jessurun, Ankie M Harmsze, Otto Bekers, Aalt Bast
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug safety (2024)
Marjolein Drent, Petal A Wijnen, Naomi T Jessurun, Ankie M Harmsze, Otto Bekers, Aalt Bast
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug safety 47 (4) (2024)
Marjolein Drent, Petal A Wijnen, Naomi T Jessurun, Ankie M Harmsze, Otto Bekers, Aalt Bast
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug safety 47 (4) (2024)
Marjolein Drent, Petal A Wijnen, Naomi T Jessurun, Ankie M Harmsze, Otto Bekers, Aalt Bast
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug safety 47 (4) (2024)
Marjolein Drent, Petal A Wijnen, Naomi T Jessurun, Ankie M Harmsze, Otto Bekers, Aalt Bast
Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease. Drug safety 47 (4) (2024)
Crista Minderhoud, Leila S Otten, Pieter H E Hilkens, Marcel P H van den Broek, Ankie M Harmsze
Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia. British journal of clinical pharmacology 88 (7) (2022)